African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression.
暂无分享，去创建一个
R. Stratta | J. Rogers | R. Alloway | A. Lo | E. Hodge
[1] R. Stratta,et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1 , 2003, Transplantation.
[2] R. Stratta,et al. Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. , 2001, Transplantation proceedings.
[3] T. Sasaki,et al. SUCCESSFUL LONG-TERM KIDNEY-PANCREAS TRANSPLANTS REGARDLESS OF C-PEPTIDE STATUS OR RACE , 2001, Transplantation.
[4] L. Thacker,et al. Effect of race on outcome following kidney and kidney-pancreas transplantation in type I diabetics: the South-Eastern Organ Procurement Foundation experience. , 1997, Clinical transplantation.
[5] M. Mocerino,et al. Racial differences in long-term renal allograft outcome. , 1996, Transplantation proceedings.
[6] P. Terasaki,et al. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. , 1994, Transplantation.
[7] P. Kimball,et al. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. , 1991, Transplantation.